Q2 Earnings Forecast for Climb Bio Issued By Leerink Partnrs
Climb Bio, Inc. (NASDAQ:CLYM – Free Report) – Investment analysts at Leerink Partnrs dropped their Q2 2025 earnings per share (EPS) estimates for Climb Bio in a research note issued to investors on Wednesday, May 14th. Leerink Partnrs analyst T. Smith now forecasts that the company will post earnings per share of ($0.18) for the […]
Climb Bio, Inc. (NASDAQ:CLYM – Free Report) – Investment analysts at Leerink Partnrs dropped their Q2 2025 earnings per share (EPS) estimates for Climb Bio in a research note issued to investors on Wednesday, May 14th. Leerink Partnrs analyst T. Smith now forecasts that the company will post earnings per share of ($0.18) for the […]
